ISSN 2097-5724 CN 61-1535/R 主管·主办:陕西省疾病预防控制中心
疾病预防与控制 Disease Prevention and Control 医学学术期刊 双月刊
2026-02-029 临床药物与手术治疗 2026, 2(02): 113-116

瑞马唑仑与丙泊酚在老年髋部骨折全身麻醉中的应用比较

首都医科大学附属北京安贞医院南充医院(南充市中心医院)

24下载次数 0被引频次 209阅读次数 11参考文献
知网阅读全文
摘要

目的 比较瑞马唑仑与丙泊酚在老年髋部骨折全身麻醉手术患者中的应用效果。方法 回顾性选取2024年1月至2025年6月期间本院收治的共计102例老年髋部骨折全身麻醉手术患者,以麻醉用药的不同分组,丙泊酚组51例采用丙泊酚麻醉,瑞马唑仑组51例采用瑞马唑仑麻醉,比较两组患者不同时间点生命体征及呼吸抑制指标,统计不良反应发生率、术后神志恢复时间、术后谵妄发生率。结果 两组患者麻醉前(T0)的心率(HR)、平均动脉压(MAP)比较,差异无统计学意义(P>0.05),瑞马唑仑组麻醉后1 min(T1)、插管后1 min(T2)、插管后10 min(T3)的HR、MAP水平较丙泊酚组更高(P<0.05);两组患者T0、T2、T3的呼吸频率(RR)及血氧饱和度(SpO2)比较,差异无统计学意义(P>0.05),T1的SpO2比较差异无统计学意义(P>0.05),瑞马唑仑组T1的RR水平较丙泊酚组更高(P<0.05);两组患者不良反应发生率比较差异无统计学意义(P>0.05);瑞马唑仑组术后呼吸恢复时间、定向力恢复时间、睁眼时间较丙泊酚组更短(P<0.05);两组患者术后谵妄发生率、谵妄评分比较,差异无统计学意义(P>0.05)。结论 瑞马唑仑与丙泊酚在老年髋部骨折全身麻醉手术患者中的应用均具有较高安全性,不易造成术后谵妄,但瑞马唑仑更能够维持生命体征稳定,减轻呼吸抑制,缩短术后神志恢复时间。

Abstract

Objective To compare the efficacy of remimazolam and propofol in elderly patients undergoing general anesthesia for hip fracture surgery. Methods A total of 102 elderly patients with hip fractures from January 2024 to June 2025 who underwent general anesthesia in our hospital were retrospectively selected. Based on the anesthetic agents used, 51 patients in the propofol group were administered propofol, while 51 patients in the remimazolam group received remimazolam. Vital signs and respiratory suppression indicators at different time points were compared in both groups, and the incidence of adverse reactions, postoperative consciousness recovery time, and postoperative delirium rates were recorded. Results In heart rate(HR) and mean arterial pressure(MAP) before anesthesia(T0), both groups were no statistically significant differences(P>0.05). In comparison of the propofol group, the HR and MAP levels in the remimazolam group were higher at 1 minute after anesthesia(T1), 1 minute after intubation(T2), and 10 minutes after intubation(T3)(P<0.05). In respiratory rate(RR) and oxygen saturation(SpO2) at T0, T2, and T3, both groups were no statistically significant differences(P>0.05). The SpO2 difference at T1 was no statistically significant(P>0.05), but in comparison of the propofol group, the RR level in the remimazolam group was higher at T1(P<0.05). In the incidence of adverse reactions, both groups were no statistically significant differences(P>0.05). In the postoperative recovery times for respiration, orientation, and eye opening, in comparison of the propofol group, the remimazolam group was shorter(P<0.05). In postoperative delirium rates or delirium scores, both groups were no statistically significant differences(P>0.05). Conclusion Both remimazolam and propofol demonstrate high safety in elderly patients undergoing general anesthesia for hip fracture surgery, with a low risk of postoperative delirium. However, remimazolam better maintains hemodynamic stability, reduces respiratory depression, and shortens postoperative consciousness recovery time.

引用本文

按标准格式复制,或导出到文献管理软件
[1]袁圆,李松,蔡雪敏.瑞马唑仑与丙泊酚在老年髋部骨折全身麻醉中的应用比较[J].疾病预防与控制,2026,2(02):113-116.